Mutual of America Capital Management LLC purchased a new position in shares of ICU Medical, Inc. (NASDAQ:ICUI) in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund purchased 4,500 shares of the medical instruments supplier’s stock, valued at approximately $836,000.
Several other large investors have also modified their holdings of the company. Castleark Management LLC bought a new position in ICU Medical in the second quarter valued at approximately $283,000. Personal Capital Advisors Corp bought a new position in ICU Medical in the second quarter valued at approximately $1,494,000. Citigroup Inc. lifted its stake in ICU Medical by 104.3% in the second quarter. Citigroup Inc. now owns 17,190 shares of the medical instruments supplier’s stock valued at $2,965,000 after buying an additional 8,775 shares in the last quarter. Fiera Capital Corp bought a new position in ICU Medical in the second quarter valued at approximately $36,962,000. Finally, Royce & Associates LP lifted its stake in ICU Medical by 26.7% in the second quarter. Royce & Associates LP now owns 47,400 shares of the medical instruments supplier’s stock valued at $8,177,000 after buying an additional 10,000 shares in the last quarter. Institutional investors own 77.14% of the company’s stock.
ICUI has been the topic of a number of recent analyst reports. Zacks Investment Research upgraded shares of ICU Medical from a “sell” rating to a “hold” rating in a report on Wednesday, October 11th. KeyCorp assumed coverage on shares of ICU Medical in a report on Tuesday, October 17th. They set a “sector weight” rating on the stock. BidaskClub downgraded shares of ICU Medical from a “hold” rating to a “sell” rating in a report on Wednesday, August 9th. Finally, Gabelli reiterated a “buy” rating on shares of ICU Medical in a report on Friday, August 11th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $193.00.
Shares of ICU Medical, Inc. (ICUI) opened at $209.15 on Tuesday. The firm has a market cap of $4,127.77, a PE ratio of 80.41 and a beta of 0.33. The company has a debt-to-equity ratio of 0.07, a quick ratio of 3.01 and a current ratio of 4.65. ICU Medical, Inc. has a 52-week low of $127.00 and a 52-week high of $210.95.
ICU Medical (NASDAQ:ICUI) last posted its earnings results on Thursday, November 9th. The medical instruments supplier reported $1.12 EPS for the quarter, topping analysts’ consensus estimates of $0.77 by $0.35. The firm had revenue of $343.20 million during the quarter, compared to analysts’ expectations of $328.56 million. ICU Medical had a net margin of 2.79% and a return on equity of 4.81%. The business’s revenue for the quarter was up 253.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.35 earnings per share. analysts expect that ICU Medical, Inc. will post -3.52 EPS for the current fiscal year.
In other ICU Medical news, CEO Vivek Jain sold 2,200 shares of the stock in a transaction that occurred on Monday, October 9th. The shares were sold at an average price of $190.91, for a total transaction of $420,002.00. Following the completion of the sale, the chief executive officer now owns 44,111 shares of the company’s stock, valued at approximately $8,421,231.01. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Joseph R. Saucedo sold 9,000 shares of the firm’s stock in a transaction that occurred on Monday, October 9th. The stock was sold at an average price of $189.46, for a total transaction of $1,705,140.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 120,247 shares of company stock valued at $22,708,888. 13.60% of the stock is owned by company insiders.
TRADEMARK VIOLATION NOTICE: This piece was first posted by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international trademark & copyright law. The original version of this piece can be accessed at https://www.truebluetribune.com/2017/11/14/4500-shares-in-icu-medical-inc-icui-acquired-by-mutual-of-america-capital-management-llc.html.
ICU Medical Profile
ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.